­
­
­
­

Inventi Impact: Preventive & Social Medicines

Articles

  • Inventi:hpsm/25152/18
    Challenges in Assessing Outcomes among Infants of Pregnant HIV-Positive Women Receiving ART in\nUganda
    01-Jan-1970 Research 2018 : April - June
    Barbara Castelnuovo, Frank Mubiru, Ivan Kalule, Shadia Nakalema, Agnes Kiragga

    Since 2012, theWHOrecommends lifelongARTwith TDF+FTC/3TC+EFV for all HIV-positive pregnant and breastfeedingwomen\n(Option B-plus). In this analysis we describe the proportion of early and late transmission in mothers with high retention in\nKampala, Uganda. We included 700 pregnant women from January 2012 to August 2014 with a follow-up extended to August\n2016; themedian age was 31 years (IQR: 26ââ?¬â??35), 36.3% inWHOstage 3/4; median CD4 count was 447 cells/

    How to Cite this Article
    CC Compliant Citation: Barbara Castelnuovo, Frank Mubiru, Ivan Kalule, Shadia Nakalema, and Agnes Kiragga, â??Challenges in Assessing\nOutcomes among Infants of Pregnant HIV-Positive Women Receiving ART in Uganda,â? AIDS Research and Treatment, vol. 2017, Article\nID 3202737, 4 pages, 2017. doi:10.1155/2017/3202737, https://creativecommons.org/licenses/by/4.0/.
    Download Full Text